High-throughput synthesis of single-layer MoS2 nanosheets as a near-infrared photothermal-triggered drug delivery for effective cancer therapy.

We report here a simple, high-yield yet low-cost approach to design single-layer MoS2 nanosheets with controllable size via an improved oleum treatment exfoliation process. By decorating MoS2 nanosheets with chitosan, these functionalized MoS2 nanosheets have been developed as a chemotherapeutic drug nanocarrier for near-infrared (NIR) photothermal-triggered drug delivery, facilitating the combination of chemotherapy and photothermal therapy into one system for cancer therapy. Loaded doxorubicin could be controllably released upon the photothermal effect induced by 808 nm NIR laser irradiation. In vitro and in vivo tumor ablation studies demonstrate a better synergistic therapeutic effect of the combined treatment, compared with either chemotherapy or photothermal therapy alone. Finally, MoS2 nanosheets can also be used as a promising contrast agent in X-ray computed tomography imaging due to the obvious X-ray absorption ability of Mo. As a result, the high-throughput oleum treatment exfoliation process could be extended for fabricating other 2D nanomaterials, and the NIR-triggered drug release strategy was encouraging for simultaneous imaging-guided cancer theranostic application.

[1]  Haiqing Hu,et al.  Engineering of a Pluronic F127 functionalized magnetite/graphene nanohybrid for chemophototherapy , 2014, Nanotechnology.

[2]  Na Li,et al.  Anisotropic gold nanoparticles: synthesis, properties, applications, and toxicity. , 2014, Angewandte Chemie.

[3]  Zhenhua Li,et al.  Hydrophobic Anticancer Drug Delivery by a 980 nm Laser‐Driven Photothermal Vehicle for Efficient Synergistic Therapy of Cancer Cells In Vivo , 2013, Advanced materials.

[4]  J. Coleman,et al.  Liquid Exfoliation of Layered Materials , 2013, Science.

[5]  T. Lawrence,et al.  Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair , 2013, Clinical Cancer Research.

[6]  Chunhai Fan,et al.  Single-layer MoS2-based nanoprobes for homogeneous detection of biomolecules. , 2013, Journal of the American Chemical Society.

[7]  Rongqin Huang,et al.  Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma. , 2013, Journal of the American Chemical Society.

[8]  Oliver G. Schmidt,et al.  Hierarchical MoS2/Polyaniline Nanowires with Excellent Electrochemical Performance for Lithium‐Ion Batteries , 2013, Advanced materials.

[9]  Hyung J. Kim,et al.  Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles. , 2013, ACS nano.

[10]  Kai Yang,et al.  Nano-graphene in biomedicine: theranostic applications. , 2013, Chemical Society reviews.

[11]  Hongzheng Chen,et al.  Graphene-like two-dimensional materials. , 2013, Chemical reviews.

[12]  C Jeffrey Brinker,et al.  Chemically exfoliated MoS2 as near-infrared photothermal agents. , 2012, Angewandte Chemie.

[13]  Qing Hua Wang,et al.  Electronics and optoelectronics of two-dimensional transition metal dichalcogenides. , 2012, Nature nanotechnology.

[14]  Xiaogang Qu,et al.  Long-circulating Er3+-doped Yb2O3 up-conversion nanoparticle as an in vivo X-Ray CT imaging contrast agent. , 2012, Biomaterials.

[15]  Lehui Lu,et al.  Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications. , 2012, Accounts of chemical research.

[16]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[17]  Jing Kong,et al.  van der Waals epitaxy of MoS₂ layers using graphene as growth templates. , 2012, Nano letters.

[18]  Menachem Motiei,et al.  Nanoparticles as computed tomography contrast agents: current status and future perspectives. , 2012, Nanomedicine.

[19]  K. Syrigos,et al.  Chemotherapy-induced neutropenia in lung cancer patients: the role of antibiotic prophylaxis. , 2011, Cancer letters.

[20]  Zhiyuan Zeng,et al.  Single-layer semiconducting nanosheets: high-yield preparation and device fabrication. , 2011, Angewandte Chemie.

[21]  Hisato Yamaguchi,et al.  Photoluminescence from chemically exfoliated MoS2. , 2011, Nano letters.

[22]  Mustafa Lotya,et al.  Large‐Scale Exfoliation of Inorganic Layered Compounds in Aqueous Surfactant Solutions , 2011, Advanced materials.

[23]  I. Aksay,et al.  High surface area tapes produced with functionalized graphene. , 2011, ACS nano.

[24]  A. Radenović,et al.  Single-layer MoS2 transistors. , 2011, Nature nanotechnology.

[25]  N. Halas,et al.  Visualizing light-triggered release of molecules inside living cells. , 2010, Nano letters.

[26]  R. Ruoff,et al.  Graphene and Graphene Oxide: Synthesis, Properties, and Applications , 2010, Advanced materials.

[27]  Chun Li,et al.  Near-infrared light triggers release of Paclitaxel from biodegradable microspheres: photothermal effect and enhanced antitumor activity. , 2010, Small.

[28]  Michael J Sailor,et al.  Cooperative Nanoparticles for Tumor Detection and Photothermally Triggered Drug Delivery , 2009, Advanced materials.

[29]  Zhuang Liu,et al.  A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice. , 2009, Nature nanotechnology.

[30]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[31]  D. Braun,et al.  Toward self-assembly of nanoparticles on polymeric microshells: near-IR release and permeability. , 2008, ACS nano.

[32]  S. Stankovich,et al.  Graphene-based composite materials , 2006, Nature.

[33]  Andre K. Geim,et al.  Electric Field Effect in Atomically Thin Carbon Films , 2004, Science.

[34]  S. Morrison,et al.  Single-layer MoS2 , 1986 .

[35]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[36]  W. Miller,et al.  Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. , 2001, Blood.

[37]  R. Dorr,et al.  Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function. , 1995, Cancer treatment reviews.